Objective: A methodology is introduced for the development of an internal dosimetry prediction toolkit for nuclear medical pediatric applications. The proposed study exploits Artificial Intelligence techniques using Monte Carlo simulations as ground truth for accurate prediction of absorbed doses per organ prior to the imaging acquisition considering only personalized anatomical characteristics of any new pediatric patient.

Approach: GATE Monte Carlo simulations were performed using a population of computational pediatric models to calculate the specific absorbed dose rates (SADRs) in several organs. A simulated dosimetry database was developed for 28 pediatric phantoms (age range 2–17 years old, both genders) and 5 different radiopharmaceuticals. Machine Learning regression models were trained on the produced simulated dataset, with leave one out cross validation for the prediction model evaluation. Hyperparameter optimization and ensemble learning techniques for a variation of input features were applied for achieving the best predictive power, leading to the development of a SADR prediction toolkit for any new pediatric patient for the studied organs and radiopharmaceuticals. Main results. SADR values for 30 organs of interest were calculated via Monte Carlo simulations for 28 pediatric phantoms for the cases of five radiopharmaceuticals. The relative percentage uncertainty in the extracted dose values per organ was lower than 2.7%. An internal dosimetry prediction toolkit which can accurately predict SADRs in 30 organs for five different radiopharmaceuticals, with mean absolute percentage error on the level of 8% was developed, with specific focus on pediatric patients, by using Machine Learning regression algorithms, Single or Multiple organ training and Artificial Intelligence ensemble techniques.

Significance: A large simulated dosimetry database was developed and utilized for the training of Machine Learning models. The developed predictive models provide very fast results (<2 s) with an accuracy >90% with respect to the ground truth of Monte Carlo, considering personalized anatomical characteristics and the biodistribution of each radiopharmaceutical. The proposed method is applicable to other medical dosimetry applications in different patients’ populations.